Cargando…

Tocilizumab: History and Future Perspectives in the Era of COVID-19

Detalles Bibliográficos
Autores principales:	Modha, Rina, Novack, Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804467/ http://dx.doi.org/10.1016/j.jaci.2021.12.642

Ejemplares similares

Mental health in the post COVID-19 era: future perspectives
por: Costa, Ana Carla dos Santos, et al.
Publicado: (2022)

The future of scientific conferences in the era of the COVID-19 pandemic: Critical analysis and future perspectives
por: VALENTI, Antonio, et al.
Publicado: (2021)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Management of Parkinson’s Disease in the COVID-19 Pandemic and Future Perspectives in the Era of Vaccination
por: Lau, Yue Hui, et al.
Publicado: (2021)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Time for tocilizumab in COVID-19?
por: Butler, Ethan, et al.
Publicado: (2021)

Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review
por: Mallet, Jasmina, et al.
Publicado: (2021)

Thromboinflammation response to tocilizumab in COVID‐19
por: Gergi, Mansour, et al.
Publicado: (2020)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Tocilizumab for the Treatment of Rheumatoid Arthritis and Other Systemic Autoimmune Diseases: Current Perspectives and Future Directions
por: Ogata, Atsushi, et al.
Publicado: (2012)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Tocilizumab in COVID-19: Is the Temptation Worthwhile?
por: Gupta, Sachin, et al.
Publicado: (2021)

Tocilizumab for hospitalized patients with COVID-19
por: Afra, Kevin, et al.
Publicado: (2021)

Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
por: Sarhan, Neven Mohamed, et al.
Publicado: (2023)

Perspectives in Genomics The Future of Fungi in ‘omics, era
por: Silva, Roberto N.
Publicado: (2016)

Appropriate use of tocilizumab in COVID-19 infection
por: Keske, Şiran, et al.
Publicado: (2020)

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
por: Stone, John H., et al.
Publicado: (2020)

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
por: Salama, Carlos, et al.
Publicado: (2020)

Tocilizumab in COVID-19: The Cerrahpaşa-PREDICT score
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2021)

Echocardiography in the Era of COVID-19: Lessons for the Future
por: Medhane, Fitsumberhan, et al.
Publicado: (2021)

Deceased Donor Liver Transplantation in India in the COVID-19 Era: Current Scenario and Future Perspectives
por: Pahari, Hirak, et al.
Publicado: (2020)

Tocilizumab and COVID-19: Timing of administration assessment
por: Richier, Q., et al.
Publicado: (2022)

Tocilizumab and COVID-19: Timing of Administration and Efficacy
por: Abidi, Emna, et al.
Publicado: (2022)

Neues zu Tocilizumab bei COVID-19
por: Borchers, Moritz
Publicado: (2022)

TOCILIZUMAB IN COVID-19: EAST-AFRICAN EXPERIENCE
por: SHAH, R., et al.
Publicado: (2022)

Tocilizumab is recommended for the treatment of severe COVID-19
por: Zhou, Yonggang, et al.
Publicado: (2020)

Tocilizumab and liver injury in patients with COVID-19
por: Serviddio, Gaetano, et al.
Publicado: (2020)

Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Fioravanti, Antonella, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in COVID-19 patients
por: Zheng, Kai-Lian, et al.
Publicado: (2020)

Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Tocilizumab in COVID-19: enthusiasm vs. evidence
por: Zeña-Huancas, Paola, et al.
Publicado: (2021)

Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics
por: Elhazmi, Alyaa, et al.
Publicado: (2023)

The Butantan Institute: History and Future Perspectives
por: De Franco, Marcelo, et al.
Publicado: (2014)

History and future perspectives of barley genomics
por: Sato, Kazuhiro
Publicado: (2020)

Plant Adaptogens—History and Future Perspectives
por: Todorova, Velislava, et al.
Publicado: (2021)

Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
por: Ip, Andrew, et al.
Publicado: (2020)

Predictors of Mortality in Tocilizumab-Treated Severe COVID-19
por: Pagkratis, Konstantinos, et al.
Publicado: (2022)

Lack of tocilizumab effect on mortality in COVID19 patients
por: Holt, Gregory E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6s45rgn6stscshmr3cdmkb83a0